-
1دورية أكاديمية
المؤلفون: Dittrich, C, Sevelda, P, Salzer, H, Obermair, A, Speiser, P, Breitenecker, G, Schemper, M, Kaider, A, Austrian Ovarian Canc Study Grp
مصطلحات موضوعية: platinum dose-intensity, cisplatin/carboplatin combination therapy, ovarian cancer, randomised trial, phase III study, Gynecologic-Oncology-Group, Combination Chemotherapy, Residual Disease, Carcinoma, Trial, Intensification, Doxorubicin, Regimens
العلاقة: orcid:0000-0003-2199-1117
-
2دورية أكاديمية
المؤلفون: Obermair, A, Sevelda, P
مصطلحات موضوعية: ovarian cancer, prognosis, second-look laparotomy, secondary cytoreductive surgery, survival, Long-Term Survival, 2nd-Look Laparotomy, Improves Survival, Carcinoma, Therapy, Time, 2nd
العلاقة: orcid:0000-0003-2199-1117
-
3دورية أكاديمية
المؤلفون: Obermair, A, Petru, E, Windbichler, G, Peters-Engl, C, Graf, AH, Stummvoll, W, Kaider, A, Kurschel, S, Kolbl, H, Sevelda, P
مصطلحات موضوعية: anemia, hemoglobin, ovarian cancer, prognosis, Erythropoietin, Chemotherapy, Carcinoma, Hypoxia, Models, Life, 1306 Cancer Research, 2730 Oncology
العلاقة: orcid:0000-0003-2199-1117
-
4دورية أكاديمية
المؤلفون: Peters-Engl, C., Obermair, A., Heinzl, H., Buxbaum, P., Sevelda, P., Medl, M.
مصطلحات موضوعية: Ovarian cancer, Ca 125, Prognosis
العلاقة: orcid:0000-0003-2199-1117
-
5دورية أكاديمية
المؤلفون: Sevelda, P., Kurz, C., Obermair, A., Vavra, N., Breitenecker, G., Czerwenka, K., Dittrich, C., Salzer, H.
مصطلحات موضوعية: dose intensity, ovarian cancer, platinum treatment, 2700 Medicine
العلاقة: orcid:0000-0003-2199-1117
-
6دورية أكاديمية
المؤلفون: Marth, Christian, Hiebl, Sonja, Oberaigner, Willi, Winter, Raimund, Leodolter, Sepp, Sevelda, Paul
المصدر: International Journal of Gynecological Cancer; Jan2009, Vol. 19 Issue 1, p94-102, 9p
-
7دورية أكاديمية
المؤلفون: Colombo, N.1 (AUTHOR), Gantzer, J.2 (AUTHOR), Ataseven, B.3 (AUTHOR), Cropet, C.4 (AUTHOR), Scambia, G.5 (AUTHOR), Herrero, A.6 (AUTHOR), Sevelda, P.7 (AUTHOR), Kobayashi, H.8 (AUTHOR), Vuylsteke, P.9 (AUTHOR), Mirza, M.R.10 (AUTHOR), Priou, F.11 (AUTHOR), Buderath, P.12 (AUTHOR), Pisano, C.13 (AUTHOR), Lainez, N.14 (AUTHOR), Guillemet, C.15 (AUTHOR), Burges, A.16 (AUTHOR), Sverdlin, R.17 (AUTHOR), El-Balat, A.18 (AUTHOR), Raban, N.19 (AUTHOR), Ray-Coquard, I.L.20 (AUTHOR)
المصدر: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS614-S614. 1p.
مصطلحات موضوعية: *OLAPARIB, *OVARIAN cancer, *BEVACIZUMAB, *DIAGNOSIS